Amplius Wealth Advisors’s Cardinal Health CAH Stock Holding History

Amplius Wealth Advisors’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-61	Closed	-$3K	–	270
2021 Q4	$3K	Buy	+61	New	+$2.99K	﹤0.01%	770

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Amplius Wealth Advisors's CAH Position: Q1 2022 in Review

Amplius Wealth Advisors sold out of Cardinal Health (CAH) in Q1 2022, closing a stake of 61 shares — an estimated $3K sold.

Amplius Wealth Advisors first reported a position in CAH in Q4 2021 and held it in 1 quarter. The position peaked at $3K in Q4 2021. 784 funds tracked by Wall St. Rank hold CAH as of Q1 2022.

Amplius Wealth Advisors reported no remaining Cardinal Health position as of Q1 2022 after selling out during the quarter.
Amplius Wealth Advisors sold 61 Cardinal Health shares in Q1 2022, an estimated $3K.
Amplius Wealth Advisors first reported a position in Cardinal Health in Q4 2021 and held it in 1 quarter.
Amplius Wealth Advisors's Cardinal Health position peaked at $3K in Q4 2021.
784 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2022.

Based on Amplius Wealth Advisors's 13F filing for Q1 2022, filed 9 May 2022.